<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>DUSP4 (MKP-2), a member of the <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinase phosphatase (MKP) family and potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor, negatively regulates the MAPKs (<z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein kinases) ERK, p38 and JNK </plain></SENT>
<SENT sid="1" pm="."><plain>MAPKs play a crucial role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development and progression </plain></SENT>
<SENT sid="2" pm="."><plain>Previously, using microarray analyses we found a conspicuously frequent overexpression of DUSP4 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) with high frequent microsatellite instability (MSI-H) compared to microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Here we studied DUSP4 expression on <z:chebi fb="2" ids="33699">mRNA</z:chebi> level in 38 CRC (19 MSI-H and 19 MSS) compared to matched <z:mpath ids='MPATH_458'>normal</z:mpath> tissue as well as in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines by RT-qPCR </plain></SENT>
<SENT sid="4" pm="."><plain>DUSP4 was overexpressed in <z:hpo ids='HP_0000001'>all</z:hpo> 19 MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and in 14 MSS <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Median expression levels in MSI-H <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were significantly higher than in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> (p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Consistently, MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines showed 6.8-fold higher DUSP4 <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e> cell lines </plain></SENT>
<SENT sid="7" pm="."><plain>DUSP4 expression was not regulated by promoter methylation since no methylation was found by quantitative methylation analysis of DUSP4 promoter in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines neither in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, no DUSP4 mutation was found on genomic DNA level in four <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines </plain></SENT>
<SENT sid="9" pm="."><plain>DUSP4 overexpression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines through DUSP4 transfection caused upregulated expression of MAPK targets CDC25A, CCND1, EGR1, FOS, MYC and CDKN1A in HCT116 as well as downregulation of mismatch repair gene MSH2 in SW480 </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, DUSP4 overexpression led to increased proliferation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines </plain></SENT>
<SENT sid="11" pm="."><plain>Our findings suggest that DUSP4 acts as an important regulator of cell growth within the MAPK pathway and causes enhanced cell growth in MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>